Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Brazilian Prospective Registry of the Inspiron EVO Drug-Eluting Stent in Complex Coronary Lesions

The objective is to evaluate the efficacy and safety of the Inspiron™ EVO drug-eluting stent in complex coronary lesions in a real-world population. Patients with symptomatic ischemic heart disease due to lesions in native coronary arteries and restenotic lesions will be treated with the Inspiron™ EVO drug-eluting stent.

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Scitech Produtos Medicos SAUpdated: Oct 2, 2026Locations: 1Duration: 12 Months
Eligibility criteria

Individuals aged 18 years or older presenting with complex coronary lesions requ... [+6]

Lesions in saphenous vein grafts or internal mammary grafts. [+2]

Status: Recruiting

The Solaris DE Sirolimus-Eluting Covered Stent for the Treatment of AV Access Stenosis or Occlusion

The goal of this clinical trial is to demonstrate the safety and efficacy of Solaris Drug-Eluting Covered Stent (Solaris DE) in the treatment of stenosis or occlusion within the outflow circuit of the dialysis access including arteriovenous (AV) fistula and synthetic AV graft. Participants will be treated with Solaris DE. Researchers will compare the treatment with investigational product to Percutaneous Transluminal Angioplasty (PTA) alone within the AV fistula cohort in order to demonstrate superiority of Solaris DE.

Participants needed: 160
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Scitech Produtos Medicos SAUpdated: Oct 6, 2026Locations: 5
Eligibility criteria

Male or female, aged ≥ 18 years on the date of inclusion. [+17]

Pregnant, breastfeeding or intending to become pregnant in the next year. [+25]